Visby Medical, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$8.0M
Doctors Paid
79
Transactions
502
2024 Total
$2.6M
Payment Breakdown by Category
Research$7.8M (97.9%)
Consulting$139,893 (1.8%)
Royalty/License$20,000 (0.3%)
Food & Beverage$4,490 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.8M | 383 | 97.9% |
| Consulting Fee | $139,893 | 36 | 1.8% |
| Royalty or License | $20,000 | 2 | 0.3% |
| Food and Beverage | $4,490 | 81 | 0.1% |
Payments by Type
Research
$7.8M
372 transactions
General
$164,384
119 transactions
Ownership
$0
11 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections (Clinical Protocol No. TP-000312) | $1.0M | 0 | 40 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $884,785 | 0 | 54 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $776,577 | 0 | 54 |
| Clinical Evaluation of the Visby Medical Flu and COVID-19 Test for the Detection and Differentiation of SARS-CoV-2, Influenza A, and Influenza B Viral RNA | $772,295 | 0 | 60 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections/Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA/Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis using self-collected vaginal swabs | $602,915 | 0 | 12 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $516,289 | 0 | 12 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $384,621 | 0 | 11 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $375,811 | 0 | 18 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs / A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test | $357,834 | 0 | 13 |
| Clinical Evaluation of the Visby COVID-19 Test for the Detection of Viral RNA from the SARS-CoV-2 Virus (Clinical Protocol TP-000362) | $320,158 | 0 | 5 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test / A Beta Study of the Visby Sexual Health Test / Clinical Evaluation of the Visby COVID-19 Test for the Detection of Viral RNA from the SARS-CoV-2 Virus / A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $276,511 | 0 | 11 |
| TP-000612 Reproducibility/Near-cutoff Study of the Visby Medical Respiratory Health Test | $248,192 | 0 | 10 |
| TP-000669 Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $160,825 | 0 | 4 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV (Clinical Protocol No. TP-000377) / A Beta Study of the Visby Sexual Health Test (Clinical Protocol No. TP-000516) / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000558) | $153,059 | 0 | 4 |
| TP-000547 Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $137,401 | 0 | 5 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV / A Beta Study of the Visby Sexual Health Test / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test | $129,930 | 0 | 4 |
| Reproducibility/Near-cutoff Study of the Visby Medical Respiratory Health Test | $117,712 | 0 | 5 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000033) / A Beta Study of the Visby Sexual Health Test (Clinical Protocol No. TP-000516) | $117,377 | 0 | 10 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test. A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV. Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test. A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $114,683 | 0 | 9 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA / A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $81,497 | 0 | 1 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections (Clinical Protocol No. TP-000312) /TP-000547 Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $53,816 | 0 | 1 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV (Clinical Protocol No. TP-000377) / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000558) | $48,264 | 0 | 2 |
| Clinical Evaluation of the Visby COVID-19 Test Version B for the Detection of Viral RNA from the SARS-CoV-2 Virus (Clinical Protocol TP-000413) | $33,258 | 0 | 2 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs (Clinical Protocol TP-000669) | $33,116 | 0 | 5 |
| Pre-Clinical Evaluation of Visby Medical Mens Sexual Health Test | $31,967 | 0 | 2 |
| TP-000700 Pre-Clinical Evaluation of Visby Medical Mens Sexual Health Test | $18,988 | 0 | 1 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000033) | $16,935 | 0 | 6 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $13,500 | 0 | 1 |
| A Prospective Study to Collect Samples for Research and Development of Visby Medical Products Relating to Respiratory Infections (TP-000312) | $10,500 | 0 | 2 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA / Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $4,488 | 0 | 5 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Infectious Disease | $50,838 | 5 | $10,168 |
| Emergency Medicine | $45,346 | 8 | $5,668 |
| Pediatric Infectious Diseases | $20,000 | 1 | $20,000 |
| Family Medicine | $10,616 | 7 | $1,517 |
| Obstetrics & Gynecology | $10,297 | 22 | $468.05 |
| Internal Medicine | $6,064 | 4 | $1,516 |
| Family | $249.32 | 9 | $27.70 |
| Nurse Practitioner | $238.59 | 3 | $79.53 |
| General Practice | $237.64 | 1 | $237.64 |
| Physician Assistant | $139.89 | 3 | $46.63 |
| Pulmonary Disease | $115.40 | 1 | $115.40 |
| Pediatrics | $53.56 | 2 | $26.78 |
| Gynecology | $42.20 | 2 | $21.10 |
| Nutrition, Pediatric | $28.31 | 1 | $28.31 |
| Advanced Practice Midwife | $18.42 | 1 | $18.42 |
| Midwife | $18.42 | 1 | $18.42 |
| Obstetrics | $18.42 | 1 | $18.42 |
| Medical | $17.67 | 1 | $17.67 |
| Addiction Medicine | $17.39 | 1 | $17.39 |
| Women's Health | $17.22 | 1 | $17.22 |
| Hospice and Palliative Medicine | $9.07 | 1 | $9.07 |
| Clinical Pathology/Laboratory Medicine | $0 | 1 | $0 |
| Dermatology | $0 | 1 | $0 |
| Endocrinology, Diabetes & Metabolism | $0 | 1 | $0 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. Glenn Harnett, Md, MD | Emergency Medicine | Hoover, AL | $44,002 | $0 |
| Angela Caliendo, M.d., Ph.d, M.D., PH.D | Infectious Disease | Providence, RI | $20,000 | $0 |
| Richard Whitley, M.d, M.D | Pediatric Infectious Diseases | Birmingham, AL | $20,000 | $0 |
| Edward Hook | Infectious Disease | Birmingham, AL | $15,000 | $0 |
| Dr. David Relman, M.d, M.D | Infectious Disease | Palo Alto, CA | $15,000 | $0 |
| Denise Sweeney, Medical Doctor, MEDICAL DOCTOR | Obstetrics & Gynecology | Granite Bay, CA | $9,440 | $0 |
| Ina Park, Md, MD | Family Medicine | Richmond, CA | $6,000 | $0 |
| Jeffrey Klausner, Md, MD | Internal Medicine | San Leandro, CA | $5,003 | $0 |
| Joseph Chow, M.d, M.D | Family Medicine | Springville, NY | $1,763 | $0 |
| Dr. Christopher Chao, Md, MD | Family Medicine | Cary, NC | $1,738 | $0 |
| Dr. Lindsey Fish, M.d, M.D | Internal Medicine | Denver, CO | $1,000 | $0 |
| Dr. Christopher Baugh, M.d., Mba, M.D., MBA | Emergency Medicine | Boston, MA | $800.00 | $0 |
| William Geisler, Md, MD | Infectious Disease | Birmingham, AL | $500.00 | $0 |
| Lamont Tyler, Do, DO | Family Medicine | Henderson, NV | $357.22 | $0 |
| Christina Muzny | Infectious Disease | Birmingham, AL | $338.40 | $0 |
| Amanpreet Singh, Md, MD | Family Medicine | Leavenworth, KS | $282.90 | $0 |
| Dr. Nicholas Karr, M.d, M.D | Emergency Medicine | Dallas, TX | $263.32 | $0 |
| Ronak Shah | Family Medicine | Brookline, MA | $237.64 | $0 |
| Scott Prysi, M.d, M.D | General Practice | Monterey, CA | $237.64 | $0 |
| Dr. Paul Nanda, M.d, M.D | Family Medicine | Tampa, FL | $237.64 | $0 |
| Alisa Goldberg, Md Mph, MD MPH | Obstetrics & Gynecology | Boston, MA | $194.83 | $0 |
| Dr. Danielle Roncari, Md, MD | Obstetrics & Gynecology | Boston, MA | $194.83 | $0 |
| Julia Max, Np, NP | Nurse Practitioner | Boston, MA | $194.83 | $0 |
| Dr. Kenneth Grudko, M.d, M.D | Pulmonary Disease | La Jolla, CA | $115.40 | $0 |
| Lewis Thompson, Md, MD | Obstetrics & Gynecology | Aurora, CO | $115.40 | $0 |
Ad
Top Products
- Visby Medical Sexual Health Click Test $4.2M
- Visby Medical Respiratory Health Test $3.0M
Associated Products (4)
Payment Categories
- Food & Beverage $4,490
- Consulting $139,893
- Research $7.8M
- Royalties $20,000
About Visby Medical, Inc.
Visby Medical, Inc. has made $8.0M in payments to 79 healthcare providers, recorded across 502 transactions in the CMS Open Payments database. In 2024, the company paid $2.6M. The top product by payment volume is Visby Medical Sexual Health Click Test ($4.2M).
Payments were distributed across 24 medical specialties. The top specialty by payment amount is Infectious Disease ($50,838 to 5 doctors).
Payment categories include: Food & Beverage ($4,490), Consulting ($139,893), Research ($7.8M), Royalties ($20,000).
Visby Medical, Inc. is associated with 4 products in the CMS Open Payments database, including Visby Medical Sexual Health Click Test, Visby Medical Respiratory Health Test, and Visby Medical COVID-19 Test.